RxDoctor Payments Data

Elliot Shin

Family Medicine · Las Vegas, NVNPI 1275554057

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $8,379 of the $10,921 with a category attached, or 76.7%. 7 manufacturers reported payments, led by Merck at 41.8% of the total. Reporting peaked in 2023 at $8,990 and has fallen 83.0% since, to $1,532 in 2025. Among family medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,921in general payments, 2019–2025

Across 59 payments — averaging $185.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$5K
  • Chiesi USA, Inc.$4K
  • Biogen$2K
  • Eli Lilly$434
  • Si-bone, Inc.$128
  • Galderma Laboratories, L.p.$109
  • plus $92 from 1 others
$2,100,664in research payments, 2019–2025

Across 1,092 payments — averaging $1923.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$501K
  • Incyte Corporation$304K
  • Braintree Laboratories, Inc.$169K
  • Amgen$147K
  • Sanofi US Services Inc.$140K
  • Alnylam Pharmaceuticals Inc.$137K
  • plus $702K from 16 others

What the payments were for

  • Travel & lodging$8,37977%
  • Food & beverage$2,54223%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck36$4,568
Chiesi USA, Inc.5$3,774
Biogen13$1,816
Eli Lilly2$434
Si-bone, Inc.1$128
Galderma Laboratories, L.p.1$109
Novo Nordisk1$92

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,921 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.

See all family medicine providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humalog Kwikpen U-200Insulin Lispro11$5,635
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,130

Paid to pharmacies, not to this prescriber.

Other family medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →